1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6FE73F006714E0129002585DF00439EAD
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/FE73F006714E0129002585DF00439EAD?OpenDocument
18
19OpenDocument
2018.208.126.232
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Business Operations » Information Technology

Document Excerpt: Evolution of Technology Platforms during the Global COVID-19 Pandemic and Beyond

DB Image

Excerpt in Cart

ID: MD-734


Features:

9 Info Graphics

20 Data Graphics

490+ Metrics

25 Narratives


Pages/Slides: 5


Published: 2020


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5634 "Evolution of Technology Platforms during the Global COVID-19 Pandemic and Beyond”.

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Medical Device; Laboratories; Biopharmaceutical; Manufacturing; Consumer Products; Consulting; Science; Marketing; Clinical Research


Companies Profiled:
Abbott; ADC Therapeutics; Advanced Accelerator Applications; Align Technology; Alkem; Alkermes; Allergan; Almirall; Alnylam Pharmaceuticals; AstraZeneca; Bayer; Boehringer Ingelheim; B. Braun; Chiesi; Daiichi Sankyo; Deciphera Pharmaceuticals; DiaSorin; Eisai; EMD Serono; GE Healthcare; Grünenthal; Ipsen; IDEXX Laboratories; Kyowa Kirin; Lundbeck; Merck; Nabriva Therapeutics; Novartis; Proteus Digital Health; Sandoz; Sanofi Genzyme; Santen; Takeda Pharmaceuticals; The Stem; Thermo Fisher Scientific; UCB Pharma; Vifor Pharma; Wellspect HealthCare; West 53rd St Digital; Worldwide Clinical Trials

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.